A feasibility randomized controlled trial testing the use of indocyanine green fluorescence image-guidance in liver surgery compared to standard liver surgery alone in reducing microscopic positive tumor margin resection rate with an embedded qualitative study: the I-FIGS study protocol

Rahi Karmarkar, Jos Latour, Joanne Hosking, Pavith Jayaraj, Somaiah Aroori
{"title":"A feasibility randomized controlled trial testing the use of indocyanine green fluorescence image-guidance in liver surgery compared to standard liver surgery alone in reducing microscopic positive tumor margin resection rate with an embedded qualitative study: the I-FIGS study protocol","authors":"Rahi Karmarkar, Jos Latour, Joanne Hosking, Pavith Jayaraj, Somaiah Aroori","doi":"10.1093/jsprm/snad013","DOIUrl":null,"url":null,"abstract":"Abstract Indocyanine green fluorescence image-guidance (I-FIGS) is gaining global popularity in liver surgery for various applications. However, its true clinical value in reducing microscopic positive margins (R1-resection rate) remains uncertain. To address this, a multi-center randomized controlled trial (RCT) comparing I-FIGS with standard liver surgery is needed. However, due to a lack of essential information on potential R1 reduction rate, sample size, methodology, intervention delivery and patient experience, a feasibility RCT protocol has been developed to determine the viability of conducting a full-scale RCT. The aim of the study is to conduct a feasibility RCT (fRCT) with an embedded qualitative study to gather all the necessary information for a full-scale RCT. Adult patients undergoing elective liver surgery for colorectal liver metastasis (CRLMs), hepatocellular carcinoma (HCC) or peripheral cholangiocarcinoma will be eligible for the study. Forty patients will be randomly assigned to either the control group (standard liver surgery) or the intervention group (standard liver surgery + I-FIGS). Patients in the I-FIGS group will receive intravenous injection of 0.03–0.05 mg/kg indocyanine green (ICG) dye 2–4 hours before the surgery. Data will be collected on demographics, screening, recruitment and retention rates, adherence to study methods, intraoperative details, postoperative histology, and experiences of both surgeons and patients. Interviews will be conducted with selected patients and surgeons to explore their experiences with the intervention. The protocol has been approved by the West-Midlands-Solihull Research Ethics Committee and registered with ClinicalTrials.gov (NCT05616039). The results will be disseminated through academic publications, congresses, newsletters and other platforms.","PeriodicalId":93590,"journal":{"name":"Journal of surgical protocols and research methodologies","volume":"44 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of surgical protocols and research methodologies","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/jsprm/snad013","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Abstract Indocyanine green fluorescence image-guidance (I-FIGS) is gaining global popularity in liver surgery for various applications. However, its true clinical value in reducing microscopic positive margins (R1-resection rate) remains uncertain. To address this, a multi-center randomized controlled trial (RCT) comparing I-FIGS with standard liver surgery is needed. However, due to a lack of essential information on potential R1 reduction rate, sample size, methodology, intervention delivery and patient experience, a feasibility RCT protocol has been developed to determine the viability of conducting a full-scale RCT. The aim of the study is to conduct a feasibility RCT (fRCT) with an embedded qualitative study to gather all the necessary information for a full-scale RCT. Adult patients undergoing elective liver surgery for colorectal liver metastasis (CRLMs), hepatocellular carcinoma (HCC) or peripheral cholangiocarcinoma will be eligible for the study. Forty patients will be randomly assigned to either the control group (standard liver surgery) or the intervention group (standard liver surgery + I-FIGS). Patients in the I-FIGS group will receive intravenous injection of 0.03–0.05 mg/kg indocyanine green (ICG) dye 2–4 hours before the surgery. Data will be collected on demographics, screening, recruitment and retention rates, adherence to study methods, intraoperative details, postoperative histology, and experiences of both surgeons and patients. Interviews will be conducted with selected patients and surgeons to explore their experiences with the intervention. The protocol has been approved by the West-Midlands-Solihull Research Ethics Committee and registered with ClinicalTrials.gov (NCT05616039). The results will be disseminated through academic publications, congresses, newsletters and other platforms.
一项可行性随机对照试验,通过嵌入定性研究:I-FIGS研究方案,检验在肝脏手术中使用吲啶青绿荧光图像引导与单独标准肝脏手术相比在降低显微镜下肿瘤边缘阳性切除率方面的可行性
吲哚菁绿色荧光图像引导(I-FIGS)在肝脏外科手术中的各种应用越来越受到全球的欢迎。然而,它在减少显微阳性切缘(r1切除率)方面的真正临床价值仍不确定。为了解决这个问题,需要进行一项多中心随机对照试验(RCT),将I-FIGS与标准肝脏手术进行比较。然而,由于缺乏关于潜在R1减少率、样本量、方法、干预方式和患者经验的基本信息,已经制定了可行性RCT方案,以确定进行全面RCT的可行性。本研究的目的是进行可行性随机对照试验(fRCT),并进行定性研究,以收集全面随机对照试验所需的所有必要信息。接受择期肝手术治疗结肝转移(crlm)、肝细胞癌(HCC)或外周胆管癌的成年患者将有资格参加这项研究。40例患者将被随机分配到对照组(标准肝脏手术)或干预组(标准肝脏手术+ I-FIGS)。I-FIGS组术前2-4小时静脉注射吲哚菁绿(ICG)染料0.03 ~ 0.05 mg/kg。将收集人口统计学、筛查、招募和保留率、对研究方法的依从性、术中细节、术后组织学以及外科医生和患者的经验等数据。将与选定的患者和外科医生进行访谈,以探讨他们对干预的体验。该方案已获得中西部-索利赫尔研究伦理委员会的批准,并在ClinicalTrials.gov注册(NCT05616039)。研究结果将通过学术出版物、大会、通讯和其他平台传播。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信